Literature DB >> 25453343

Toll-like receptor 3 signaling inhibits simian immunodeficiency virus replication in macrophages from rhesus macaques.

Ming Sang1, Jin-Biao Liu2, Ming Dai3, Jian-Guo Wu4, Wen-Zhe Ho5.   

Abstract

Toll-like receptor 3 (TLR3) recognizes double-stranded RNA and induces multiple intracellular events responsible for innate antiviral immunity against viral infections. Here we demonstrate that TLR3 signaling of monocyte-derived macrophages (MDM) from rhesus monkeys by poly I:C inhibited simian immunodeficiency virus (SIV) infection and replication. Investigation of the mechanisms showed that TLR3 activation resulted in the induction of type I and type III interferons (IFNs) and IFN-inducible antiviral factors, including APOBEC3G (A3G), tetherin and SAMHD1. In addition, poly I:C-treated macaque macrophages expressed increased levels of CC chemokines including CCL3, CCL4 and CCL5, the ligands for HIV or SIV coreceptor CCR5. Furthermore, TLR3 signaling of macaque macrophages induced the expression of cellular microRNAs (miR-29a, -29b, -146a and -9), the newly identified intracellular SIV restriction factors. TLR3 activation-mediated anti-SIV effect could be compromised by the knockdown of IRF3 and IRF7. These findings indicate that TLR3-mediated induction of multiple viral restriction factors contribute to the inhibition of SIV infection in macaque macrophages, which support future preclinical studies using rhesus macaques to determine whether in vivo TLR3 activation is safe and beneficial for treating people infected with HIV.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CC chemokine; Interferon; Rhesus macaques; Simian immunodeficiency virus (SIV); Toll-like receptor 3 (TLR3); microRNA

Mesh:

Substances:

Year:  2014        PMID: 25453343      PMCID: PMC4258448          DOI: 10.1016/j.antiviral.2014.10.008

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  53 in total

Review 1.  A virological view of innate immune recognition.

Authors:  Akiko Iwasaki
Journal:  Annu Rev Microbiol       Date:  2012       Impact factor: 15.500

2.  SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.

Authors:  Hanna-Mari Baldauf; Xiaoyu Pan; Elina Erikson; Sarah Schmidt; Waaqo Daddacha; Manja Burggraf; Kristina Schenkova; Ina Ambiel; Guido Wabnitz; Thomas Gramberg; Sylvia Panitz; Egbert Flory; Nathaniel R Landau; Serkan Sertel; Frank Rutsch; Felix Lasitschka; Baek Kim; Renate König; Oliver T Fackler; Oliver T Keppler
Journal:  Nat Med       Date:  2012-11       Impact factor: 53.440

3.  BST-2 mediated restriction of simian-human immunodeficiency virus.

Authors:  Autumn Ruiz; David Lau; Richard S Mitchell; M Sarah Hill; Kimberly Schmitt; John C Guatelli; Edward B Stephens
Journal:  Virology       Date:  2010-08-13       Impact factor: 3.616

4.  A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages.

Authors:  Yu Zhou; Xu Wang; Manqing Liu; Quan Hu; Li Song; Li Ye; Dunjin Zhou; Wenzhe Ho
Journal:  Immunology       Date:  2010-07-16       Impact factor: 7.397

5.  SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx.

Authors:  Nadine Laguette; Bijan Sobhian; Nicoletta Casartelli; Mathieu Ringeard; Christine Chable-Bessia; Emmanuel Ségéral; Ahmad Yatim; Stéphane Emiliani; Olivier Schwartz; Monsef Benkirane
Journal:  Nature       Date:  2011-05-25       Impact factor: 49.962

6.  A novel CCR5 mutation common in sooty mangabeys reveals SIVsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivo.

Authors:  Nadeene E Riddick; Emilia A Hermann; Lamorris M Loftin; Sarah T Elliott; Winston C Wey; Barbara Cervasi; Jessica Taaffe; Jessica C Engram; Bing Li; James G Else; Yingying Li; Beatrice H Hahn; Cynthia A Derdeyn; Donald L Sodora; Cristian Apetrei; Mirko Paiardini; Guido Silvestri; Ronald G Collman
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

7.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.

Authors:  Kasia Hrecka; Caili Hao; Magda Gierszewska; Selene K Swanson; Malgorzata Kesik-Brodacka; Smita Srivastava; Laurence Florens; Michael P Washburn; Jacek Skowronski
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

8.  IFN-λ3 inhibits HIV infection of macrophages through the JAK-STAT pathway.

Authors:  Man-Qing Liu; Dun-Jin Zhou; Xu Wang; Wang Zhou; Li Ye; Jie-Liang Li; Yi-Zhong Wang; Wen-Zhe Ho
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

9.  Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens.

Authors:  N Kadowaki; S Ho; S Antonenko; R W Malefyt; R A Kastelein; F Bazan; Y J Liu
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

Review 10.  Macrophages and their relevance in Human Immunodeficiency Virus Type I infection.

Authors:  Herwig Koppensteiner; Ruth Brack-Werner; Michael Schindler
Journal:  Retrovirology       Date:  2012-10-04       Impact factor: 4.602

View more
  11 in total

1.  Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice.

Authors:  Silvio Antoniak; Kohei Tatsumi; Michael Bode; Swetha Vanja; Julie C Williams; Nigel Mackman
Journal:  J Innate Immun       Date:  2016-11-08       Impact factor: 7.349

2.  Toll-like receptor-3 mediates HIV-1 transactivation via NFκB and JNK pathways and histone acetylation, but prolonged activation suppresses Tat and HIV-1 replication.

Authors:  Biju Bhargavan; Shawna M Woollard; Georgette D Kanmogne
Journal:  Cell Signal       Date:  2015-11-11       Impact factor: 4.315

3.  Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients.

Authors:  Maura Statzu; Letizia Santinelli; Agnese Viscido; Claudia Pinacchio; Giancarlo Ceccarelli; Claudia Rotondo; Giuseppe Corano Scheri; Ivano Mezzaroma; Ombretta Turriziani; Guido Antonelli; Gabriella d'Ettorre; Carolina Scagnolari
Journal:  Med Microbiol Immunol       Date:  2018-12-18       Impact factor: 4.148

4.  HIV infection suppresses TLR3 activation-mediated antiviral immunity in microglia and macrophages.

Authors:  Hang Liu; Run-Hong Zhou; Yu Liu; Le Guo; Xu Wang; Wen-Hui Hu; Wen-Zhe Ho
Journal:  Immunology       Date:  2020-05-03       Impact factor: 7.215

5.  Gut immune dysfunction through impaired innate pattern recognition receptor expression and gut microbiota dysbiosis in chronic SIV infection.

Authors:  T W Glavan; C A Gaulke; C Santos Rocha; S Sankaran-Walters; L A Hirao; M Raffatellu; G Jiang; A J Bäumler; L R Goulart; S Dandekar
Journal:  Mucosal Immunol       Date:  2015-09-16       Impact factor: 7.313

6.  Interferon regulatory factor 3 is a key regulation factor for inducing the expression of SAMHD1 in antiviral innate immunity.

Authors:  Shen Yang; Yuan Zhan; Yanjun Zhou; Yifeng Jiang; Xuchen Zheng; Lingxue Yu; Wu Tong; Fei Gao; Liwei Li; Qinfeng Huang; Zhiyong Ma; Guangzhi Tong
Journal:  Sci Rep       Date:  2016-07-14       Impact factor: 4.379

7.  Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells.

Authors:  David Alvarez-Carbonell; Yoelvis Garcia-Mesa; Stephanie Milne; Biswajit Das; Curtis Dobrowolski; Roxana Rojas; Jonathan Karn
Journal:  Retrovirology       Date:  2017-02-06       Impact factor: 4.602

8.  Toll-Interacting Protein Suppresses HIV-1 Long-Terminal-Repeat-Driven Gene Expression and Silences the Post-Integrational Transcription of Viral Proviral DNA.

Authors:  Fu-Chun Yang; Wen-Dong Kuang; Chuan Li; Wei-Wei Sun; Di Qu; Jian-Hua Wang
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

Review 9.  The role of BST-2/Tetherin in host protection and disease manifestation.

Authors:  Wadie D Mahauad-Fernandez; Chioma M Okeoma
Journal:  Immun Inflamm Dis       Date:  2015-12-07

10.  The G1/S Specific Cyclin D2 Is a Regulator of HIV-1 Restriction in Non-proliferating Cells.

Authors:  Roger Badia; Maria Pujantell; Eva Riveira-Muñoz; Teresa Puig; Javier Torres-Torronteras; Ramón Martí; Bonaventura Clotet; Rosa M Ampudia; Marta Vives-Pi; José A Esté; Ester Ballana
Journal:  PLoS Pathog       Date:  2016-08-19       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.